Kate Haviland, CHIEF EXECUTIVE OFFICER at Blueprint Medicines Corp (BPMC), sold 24,928 shares at $90.69 ($2.3M) on 2024-03-07, disclosed to the SEC on 2024-03-11.
Seasonal sale ($2.3M) by CHIEF EXECUTIVE OFFICER — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.69 | 12,464 | $1.1M | 50.0% |
| 2 | $90.69 | 12,464 | $1.1M | 50.0% |
| Total | $90.69 avg | 24,928 | $2.3M | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2023-03-08 | $597K | — | Filing → |